E3A Healthcare will complete the development and optimization of Nora in HSITP. Nora is the world’s first non-drug, non-surgical treatment device for endometriosis, based on neuromodulation and brain–computer interface technologies. Powered by an AI-driven closed-loop system, Nora enables personalized therapy, improving clinical efficacy and patient adherence. It offers a safe, accessible, and sustainable medical device solution for women’s health, empowering over 300 million women worldwide to move away from the overuse of hormone-based therapies.